Navigation Links
Array BioPharma Announces Management Team Change
Date:11/21/2013

BOULDER, Colo., Nov. 21, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) announced today that Kevin Koch, Ph.D., President and Chief Scientific Officer, will be leaving Array to pursue other opportunities.

(Photo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

"The board and executive team thank Dr. Koch for his leadership and contributions to the success of Array over the past 15 years.  During this time, Array advanced 19 novel compounds into clinical trials, of which 14 remain in active development," said Ron Squarer, Chief Executive Officer of Array.  "With several of these programs in late stage trials, and a strong management team in place, Array is well-positioned for continued success."

Array remains committed to its world-class discovery organization and its existing research partnerships.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, ARRY-520, for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and MEK162 (Novartis).  For more information on Array, please go to www.arraybiopharma.com

CONTACT:

Array BioPharma


Tricia Haugeto, (303) 386-1193


thaugeto@arraybiopharma.com


'/>"/>
SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences
2. Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes
3. ARRAYit Corporation Receives Purchase Order from ChemBio
4. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
5. Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013
6. Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
7. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
8. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
9. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
10. Gentris Corporation Launches Next Generation Human Transcriptome Array
11. Genentech Purchases Arrayit Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):